RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
6.78
+0.11 (1.65%)
Nov 22, 2024, 4:00 PM EST - Market closed
RedHill Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 7.28 | 5.57 | 19.97 | 29.47 | 29.3 | 29.02 | Upgrade
|
| Short-Term Investments | - | - | 0.02 | 8.53 | 0.02 | 10.35 | Upgrade
|
| Trading Asset Securities | - | - | - | - | 0.48 | 8.5 | Upgrade
|
| Cash & Short-Term Investments | 7.28 | 5.57 | 19.98 | 38 | 29.79 | 47.87 | Upgrade
|
| Cash Growth | 3.75% | -72.13% | -47.42% | 27.56% | -37.77% | -9.99% | Upgrade
|
| Accounts Receivable | 0.97 | 2.59 | 34.52 | 31.68 | 28.66 | 1.22 | Upgrade
|
| Other Receivables | - | 0.69 | 0.83 | 0.85 | 0.63 | 0.42 | Upgrade
|
| Receivables | 0.97 | 3.29 | 35.35 | 32.52 | 29.29 | 1.64 | Upgrade
|
| Inventory | 3.8 | 4.39 | 11.01 | 14.81 | 6.53 | 1.88 | Upgrade
|
| Prepaid Expenses | 2.91 | 0.8 | 2.52 | 3.18 | 2.34 | 0.41 | Upgrade
|
| Restricted Cash | 0.74 | 0.79 | 16 | - | - | - | Upgrade
|
| Other Current Assets | - | 1.31 | 1.03 | 0.63 | 2.54 | 1.41 | Upgrade
|
| Total Current Assets | 15.7 | 16.14 | 85.9 | 89.15 | 70.5 | 53.21 | Upgrade
|
| Property, Plant & Equipment | 0.62 | 1.18 | 7.19 | 4.22 | 5.7 | 3.81 | Upgrade
|
| Other Intangible Assets | 5.56 | 5.58 | 65.63 | 71.64 | 87.88 | 16.93 | Upgrade
|
| Other Long-Term Assets | 0.14 | 0.15 | 0.15 | 16.17 | 16.16 | 0.15 | Upgrade
|
| Total Assets | 22.02 | 23.05 | 158.87 | 181.19 | 180.24 | 74.1 | Upgrade
|
| Accounts Payable | 1.91 | 3.28 | 4.23 | 11.66 | 11.55 | 4.18 | Upgrade
|
| Accrued Expenses | 13.85 | 12.68 | 64.59 | 50.64 | 40.46 | 5.33 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 115.22 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.37 | 0.72 | 1.03 | 1.62 | 1.71 | 0.83 | Upgrade
|
| Other Current Liabilities | 5.1 | 2.57 | 12.39 | 17.55 | 19.51 | 0.27 | Upgrade
|
| Total Current Liabilities | 21.23 | 19.24 | 197.45 | 81.47 | 73.24 | 10.62 | Upgrade
|
| Long-Term Debt | - | - | - | 83.62 | 81.39 | - | Upgrade
|
| Long-Term Leases | 0.19 | 0.46 | 6.44 | 2.57 | 3.81 | 2.98 | Upgrade
|
| Other Long-Term Liabilities | 0.54 | 1.28 | 3.37 | 4.65 | 7.95 | 0.5 | Upgrade
|
| Total Liabilities | 21.96 | 20.98 | 207.27 | 172.31 | 166.38 | 14.1 | Upgrade
|
| Common Stock | 34.79 | 21.44 | 2.84 | 1.5 | 1.05 | 0.96 | Upgrade
|
| Additional Paid-In Capital | 375.33 | 388.36 | 382.63 | 375.25 | 293.14 | 267.4 | Upgrade
|
| Retained Earnings | -410.06 | -407.74 | -433.86 | -367.87 | -280.33 | -208.36 | Upgrade
|
| Shareholders' Equity | 0.06 | 2.07 | -48.4 | 8.88 | 13.86 | 60 | Upgrade
|
| Total Liabilities & Equity | 22.02 | 23.05 | 158.87 | 181.19 | 180.24 | 74.1 | Upgrade
|
| Total Debt | 0.56 | 1.17 | 122.69 | 87.81 | 86.9 | 3.82 | Upgrade
|
| Net Cash (Debt) | 6.72 | 4.4 | -102.71 | -49.81 | -57.11 | 44.06 | Upgrade
|
| Net Cash Growth | 42.05% | - | - | - | - | -17.16% | Upgrade
|
| Net Cash Per Share | 8.58 | 16.96 | -1666.53 | -1070.52 | -1567.75 | 1483.80 | Upgrade
|
| Filing Date Shares Outstanding | 1.18 | 0.79 | 0.09 | 0.05 | 0.05 | 0.04 | Upgrade
|
| Total Common Shares Outstanding | 1.18 | 0.79 | 0.09 | 0.05 | 0.04 | 0.04 | Upgrade
|
| Working Capital | -5.53 | -3.1 | -111.55 | 7.68 | -2.74 | 42.6 | Upgrade
|
| Book Value Per Share | 0.05 | 2.63 | -519.34 | 168.46 | 361.06 | 1701.22 | Upgrade
|
| Tangible Book Value | -5.5 | -3.51 | -114.03 | -62.77 | -74.02 | 43.08 | Upgrade
|
| Tangible Book Value Per Share | -4.68 | -4.46 | -1223.51 | -1191.42 | -1927.57 | 1221.29 | Upgrade
|
| Machinery | - | 1.06 | 1.2 | 1.02 | 0.75 | 0.53 | Upgrade
|
| Leasehold Improvements | - | 0.38 | 0.38 | 0.36 | 0.36 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.